News

Deal Announcements

Aviir Books $30 Million VC Investment

Wednesday, December 21, 2011 5:31:00 AM PDT | VentureDeal Staff
Palo Alto, California  --  Biotechnology company Aviir has garnered $30 million in a new round of institutional venture capital investment.

Aviir has built what it calls "cutting-edge, convenient diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease."

Investors in the round included Merck, Bay City Capital, New Leaf Venture Partners and Aberdare Ventures.

The company said it would use the funding proceeds to continue to commercialize its proprietary cardiac risk assessment technology.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1